SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
4.920
-0.010 (-0.20%)
Nov 28, 2025, 1:00 PM EST - Market closed
SOPHiA GENETICS Market Cap
SOPHiA GENETICS has a market cap or net worth of $333.81 million as of November 28, 2025. Its market cap has increased by 25.92% in one year.
Market Cap
333.81M
Enterprise Value
315.57M
1-Year Change
25.92%
Ranking
Category
Stock Price
$4.92
Market Cap Chart
Since the IPO on July 23, 2021, SOPHiA GENETICS's market cap has decreased from $1.12B to $333.81M, a decrease of -70.20%. That is a compound annual growth rate of -24.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 333.81M | 63.66% |
| Dec 31, 2024 | 203.97M | -33.51% |
| Dec 29, 2023 | 306.77M | 131.92% |
| Dec 30, 2022 | 132.27M | -85.31% |
| Dec 31, 2021 | 900.39M | -19.63% |
| Jul 23, 2021 | 1.12B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 963.72B |
| Johnson & Johnson | 495.88B |
| AbbVie | 401.89B |
| UnitedHealth Group | 299.06B |
| AstraZeneca | 287.99B |
| Merck & Co. | 260.61B |
| Novartis AG | 249.49B |
| Abbott Laboratories | 224.42B |